Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
GUADALAJARA, Mexico, March 19, 2026 (GLOBE NEWSWIRE) -- Grupo Aeroportuario del Pacífico, S.A.B. de C.V. (NYSE: PAC; BMV: GAP) (the “Company” or “GAP”) announced that today it refinanced a bank loan...
-
TORONTO, March 19, 2026 (GLOBE NEWSWIRE) -- (TSX: CGX) – Cineplex Inc. (“Cineplex” or the “Company”), Canada’s leading entertainment and media company, today announced the first amendment to its...
-
MIAMI, March 19, 2026 (GLOBE NEWSWIRE) -- SAB Biotherapeutics, Inc. (Nasdaq: SABS), a clinical-stage biopharmaceutical company developing a fully human anti-thymocyte immunoglobulin (hATG) for type...
-
미국 캘리포니아주 랜초 코르도바, March 20, 2026 (GLOBE NEWSWIRE) -- SK 팜테코 (SK pharmteco)가 자사의 바이럴 벡터 사업 내 전략적 이니셔티브를 지원하기 위한 대규모 자금 투자를 단행한다고 오늘 발표하며, 소분자, 펩타이드, 바이럴 벡터 등 세 가지 사업 부문에 걸친 장기 성장 전략을 재확인했다. SK...
-
RANCHO CORDOVA, Kalifornien, March 19, 2026 (GLOBE NEWSWIRE) -- SK pharmteco gab heute eine bedeutende Finanzierungszusage zur Unterstützung strategischer Initiativen im Bereich seines...
-
RANCHO CORDOVA, Californie, 19 mars 2026 (GLOBE NEWSWIRE) -- SK pharmteco a annoncé aujourd’hui un engagement de financement significatif visant à soutenir des initiatives stratégiques au sein de...
-
Hamilton AI raises $7.5M seed round led by TTV Capital to automate private aviation workflows with deterministic AI, improving quoting, scheduling, and ope
-
TORONTO, 19 mars 2026 (GLOBE NEWSWIRE) -- Partenaires Ninepoint LP (« Ninepoint ») est heureuse d’annoncer que Ninepoint 2026 Flow-Through Limited Partnership (la « société en commandite ») a mené à...
-
TORONTO, March 19, 2026 (GLOBE NEWSWIRE) -- Ninepoint Partners LP (“Ninepoint”) is pleased to announce that the Ninepoint 2026 Flow-Through Limited Partnership (the “Partnership”) has completed the...
-
Net proceeds from the offering will fund the commercialization of Symvess® in the vascular trauma indication and provide funding beyond key milestones such as the upcoming read-out of Phase 3 results...